Abeona Therapeutics, Inc. (ABEO)
2.505
-1.66
(-39.93%)
USD |
NASDAQ |
Nov 09, 11:35
Abeona Therapeutics Price : 2.505 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 4.02 | 4.265 | 3.95 | 4.17 | 1.050M |
| Nov 05, 2026 | 4.19 | 4.25 | 3.91 | 3.91 | 1.547M |
| Nov 04, 2026 | 4.36 | 4.42 | 4.19 | 4.22 | 881735.0 |
| Nov 03, 2026 | 4.27 | 4.400 | 4.20 | 4.25 | 1.123M |
| Nov 02, 2026 | 4.43 | 4.456 | 4.16 | 4.25 | 1.012M |
| Oct 30, 2026 | 4.50 | 4.53 | 4.305 | 4.35 | 783431.0 |
| Oct 29, 2026 | 4.54 | 4.73 | 4.470 | 4.56 | 874334.0 |
| Oct 28, 2026 | 4.46 | 4.58 | 4.44 | 4.55 | 618146.0 |
| Oct 27, 2026 | 4.33 | 4.495 | 4.30 | 4.45 | 663678.0 |
| Oct 26, 2026 | 4.39 | 4.41 | 4.305 | 4.31 | 426579.0 |
| Oct 23, 2026 | 4.42 | 4.435 | 4.29 | 4.40 | 797294.0 |
| Oct 22, 2026 | 4.46 | 4.61 | 4.38 | 4.47 | 717808.0 |
| Oct 21, 2026 | 4.62 | 4.67 | 4.50 | 4.51 | 643558.0 |
| Oct 20, 2026 | 4.43 | 4.645 | 4.40 | 4.60 | 1.394M |
| Oct 19, 2026 | 4.47 | 4.49 | 4.32 | 4.41 | 986053.0 |
| Oct 16, 2026 | 4.66 | 4.66 | 4.39 | 4.43 | 819512.0 |
| Oct 15, 2026 | 4.39 | 4.785 | 4.35 | 4.65 | 1.377M |
| Oct 14, 2026 | 4.48 | 4.51 | 4.28 | 4.36 | 1.774M |
| Oct 13, 2026 | 4.88 | 4.88 | 4.505 | 4.52 | 1.980M |
| Oct 12, 2026 | 4.93 | 4.945 | 4.855 | 4.90 | 758415.0 |
| Oct 09, 2026 | 4.94 | 5.04 | 4.885 | 4.94 | 1.285M |
| Oct 08, 2026 | 5.04 | 5.05 | 4.94 | 4.96 | 1.625M |
| Oct 07, 2026 | 4.95 | 5.10 | 4.93 | 5.08 | 738343.0 |
| Oct 06, 2026 | 5.16 | 5.16 | 4.89 | 5.01 | 1.428M |
| Oct 05, 2026 | 5.07 | 5.16 | 4.985 | 5.11 | 1.404M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 15.96 |
| ACADIA Pharmaceuticals, Inc. | 21.40 |
| Alnylam Pharmaceuticals, Inc. | 156.05 |
| Anika Therapeutics, Inc. | 14.55 |
| Savara, Inc. | 4.955 |
Price Related Metrics
| PS Ratio | 5.471 |
| Price to Book Value | 1.119 |
| Earnings Yield | -44.81% |
| Market Cap | 143.35M |